Cash & equivalents increased 63.5%
Cash & equivalents changed +63.5% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +63.5% from the comparable as-filed period.
Net income changed -22.4% from the comparable as-filed period.
Operating income changed -13.6% from the comparable as-filed period.
Operating margin changed -202 basis points from the comparable as-filed period.
Gross margin changed -135 basis points from the comparable as-filed period.
Gross profit changed -3.4% from the comparable as-filed period.
Research & development changed -2.1% from the comparable as-filed period.
Revenue changed -1.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.